Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
antonio.berretta@cvm.ox.ac.uk

Research groups

Antoniades Group: The Oxford Translational Cardiovascular Research Group

Antonio Berretta

Postdoctoral Scientist

Recent publications

ssociation Between a Distinctive Autoantibody-Associated Brainstem Sensory Syndrome and Immune Checkpoint Inhibitors.

Damato V. et al, (2022), JAMA Neurol, 79, 949 - 951

Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders.

Damato V. et al, (2022), Proc Natl Acad Sci U S A, 119

Perlecan Domain-V Enhances Neurogenic Brain Repair After Stroke in Mice.

Trout AL. et al, (2021), Transl Stroke Res, 12, 72 - 86

bsence of Neuronal Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus.

Varley JA. et al, (2020), Ann Neurol, 88, 1244 - 1250

Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms.

Ramberger M. et al, (2020), Brain, 143, 1731 - 1745

More publications